Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Remifentanil hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Remifentanil 1mg powder for solution for injection vials
1501010Q0AAAAAA
|
Remifentanil hydrochloride | Remifentanil hydrochloride | Anaesthesia | No data available |
|
Remifentanil 2mg powder for solution for injection vials
1501010Q0AAABAB
|
Remifentanil hydrochloride | Remifentanil hydrochloride | Anaesthesia | No data available |
|
Remifentanil 5mg powder for solution for injection vials
1501010Q0AAACAC
|
Remifentanil hydrochloride | Remifentanil hydrochloride | Anaesthesia | No data available |
|
Ultiva 1mg powder for solution for injection vials
1501010Q0BBAAAA
|
Ultiva | Remifentanil hydrochloride | Anaesthesia | No data available |
|
Ultiva 2mg powder for solution for injection vials
1501010Q0BBABAB
|
Ultiva | Remifentanil hydrochloride | Anaesthesia | No data available |
|
Ultiva 5mg powder for solution for injection vials
1501010Q0BBACAC
|
Ultiva | Remifentanil hydrochloride | Anaesthesia | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.